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Ab s t r a c t 
One major unmet clinical need in epilepsy is the identification of therapies to prevent or arrest 
epilepsy development in patients exposed to a potential epileptogenic insult. The 
development of such treatments has been hampered by the lack of non-invasive biomarkers 
that could be used to identify the patients at-risk, thereby allowing to design affordable 
clinical studies. Our goal was to test the predictive value of cognitive deficits and brain 
astrocyte activation for the development of epilepsy following a potential epileptogenic 
injury. We used a model of epilepsy induced by pilocarpine-evoked status epilepticus (SE) in 
21-day old rats where 60–70% of animals develop spontaneous seizures after around 70 days, 
although SE is similar in all rats. Learning was evaluated in the Morris water-maze at days 15 
and 65 post-SE, each time followed by proton magnetic resonance spectroscopy 
For measuring hippo campalmyo-Inositol levels, a marker of astrocyte activation. Rats were 
video-EEG monitored for two weeks at seven months post-SE to detect spontaneous seizures, 
then brain histology was done. Behavioral and imaging data were retrospectively analysed in 
epileptic rats and compared with non-epileptic and control animals. Rats displayed spatial 
learning deficits within three weeks from SE. However, only epilepsy-prone rats showed 
accelerated forgetting and reduced learning rate compared to both rats not developing 
epilepsy and controls. These deficits were associated with reduced hippocampal 
neurogenesis. myo-Inositol levels increased transiently in the hippocampus of SE-rats not 
developing epilepsy while this increase persisted until spontaneous seizures onset in epilepsy-
prone rats, being associated with a local increase in S100β-positive astrocytes. Neuronal cell 
loss was similar in all SE-rats. Our data show that behavioral deficits, together with a non-
invasive marker of astrocyte activation, predict which rats develop epilepsy after an acute 
injury. These measures have potential clinical relevance for identifying individuals at-risk for 
developing epilepsy following exposure to epileptogenic insults, and consequently, for 
designing adequately powered antiepileptogenesis trials. 
 
Introduction 
Epileptogenesis is a dynamic process of molecular, cellular and functional reorganization 
occurring in brain following precipitating events that lead to epilepsy (Pitkanen and Engel, 
2014). Epilepsy is one of the most prevalent brain disorders affecting around 60 million people 
worldwide (Duncan et al., 2006). It is characterized by an enduring predisposition to generate 
spontaneous seizures often associated with cognitive and psychiatric comorbidities with 
negative social consequences. One major clinical need in epilepsy is to identify 
antiepileptogenesis treatments for preventing or arresting the development of the disease in 
patients who have been exposed to potentially epileptogenic brain insults, including status 
epilepticus (SE) (Holtkamp et al., 2005; Wagenman et al., 2014). The development of such 
treatments has been hampered by the lack of non-invasive biomarkers that could be used to 
identify the patients at-risk, thereby allowing to design affordable clinical studies (Engel et al., 
2013; Pitkanen and Engel, 2014).  
Our main goal was to test if cognitive deficits and astrocyte activation in seizure susceptible 
brain areas, both phenomena occurring in human epilepsy (Elger et al., 2004; Vezzani et al., 
2012) and related animal models (Kleen et al., 2012; Vezzani et al., 2011), are biomarkers of 
epileptogenesis, thus predicting who is going to develop epilepsy after an acute brain injury. 
We used a well-established pilocarpine model of SE in 21 day-old rats where only a cohort of 
animals develops epilepsy (Marcon et al., 2009; Roch et al., 2002). This model mimics de novo 
SE in humans; SE is a relatively common clinical condition (10–41/ 100,000 population) 
(Betjemann and Lowenstein, 2015) with the majority of cases (54%) occurring in the absence 
of an antecedent diagnosis of epilepsy (Hesdorffer et al., 1998). 53% of patients (9/17)with 
de novo refractory SEwere reported to develop epilepsy (Holtkamp et al., 2005) 
and in children with non-febrile convulsive SE subsequent epilepsy occurred in 13–74% of 
cases (Raspall-Chaure et al., 2006). 
By focusing our analyses in the hippocampus, a key epileptogenic area in our animal model, 
we measured increased myo-Inositol (mIns) levels, a metabolite reflecting astrocyte 
activation (Brand et al., 1993) by in vivo proton magnetic resonance spectroscopy (1H-MRS) 
and cognitive deficits in the Morris Water Maze (MWM), a virtual version of which was 
recently developed in humans (Barkas et al., 2012). We found that both phenomena arise in 
rats before the onset of epilepsy, and predict which animals will develop the disease with high 
fidelity. Our results provide a proof-of-principle evidence of the potential predictive value of 
cognitive functions and mIns levels in seizure-prone brain areas for epilepsy development in 
individuals at high-risk following potential epileptogenic injuries. 
 
Material and methods 
 
2. Animals 
 
2.1. Male Sprague–Dawley rats (Charles River, Calco, Italy) at postnatal day (PN) 21 (with PN1 
defined as the day of birth) were used. The pups were housed with their dams at constant 
temperature (23 °C) and relative humidity (60%) with a fixed 12 h light–dark cycle and free 
access to food and water until weaning at PN21. Older animals were housed one per cage. 
For each experimental protocol described in Fig. 1, male pups were used from four 
independent litters. All experimental procedures were conducted in conformity with 
institutional guidelines that are in compliance with national (D.L. n.26, G.U. March 
4, 2014) and international guidelines and laws (EEC Council Directive 86/609, OJ L 358, 1, 
December 12, 1987, Guide for the Care and Use of Laboratory Animals, U.S. National Research 
Council, 1996), and were reviewed and approved by the intramural ethical committee.  
 
2.2. Induction and analysis of status epilepticus (SE) Lithium chloride (3 meq/kg; Merck Sharp 
& Dohme, Rome, Italy) was intraperitoneally injected in PN20 rats, 18 h before the 
subcutaneous injection of pilocarpine (Marcon et al., 2009; Roch et al., 2002) (60 mg/kg; 
Sigma-Aldrich, St. Louis, MO, USA). Controls were agematched rats injected with lithium 
chloride and an equivalent volume of vehicle (phosphate-buffered saline, PBS, pH 7.4) instead 
of pilocarpine. All animals received an injection of 10% sucrose in PBS, 2 h after 
the onset of SE to improve hydration. SE was not interrupted by any drug administration. 
 
As in both adult and pediatric populations (DeLorenzo et al., 1995; Logroscino et al., 1997; 
Raspall-Chaure et al., 2006), the mortality rate in this SE model is relatively high. A total of 59 
rats were injected with pilocarpine, and 23 rats died within the first week after SE. One rat 
was excluded from the study since he died during electrode implantation. The remaining 35 
rats were used in two different protocols that were run sequentially (Protocol 2, n = 14 
followed by Protocol 3, n = 21; Fig. 1). Since these animals were used for longitudinal 1H-MRS 
analysis, they could not be implanted with electrodes, therefore, SE was behaviourally scored 
by two independent investigators who observed rats for 6 h after pilocarpine injection. The 
following scores were used to monitor rats: score 1 (general automatisms and exploratory 
behavior) and score 2 (stage 5 seizures, bilateral forelimb clonus with rearing and falling). For 
each score, we determined the time of appearance of the first sign. Retrospective score 
analysis was done after rats were identified as epileptic or non-epileptic (see later): Score 1 
(min), non-epileptic 5.0±1.0, n=20; epileptic, 4.5±0.7, n=11; Score2 (min), none pileptic 12.1 
± 0.6; epileptic, 10.4 ± 0.6. The onset of SE was determined by the time of appearance of the 
second stage 5 seizure and was similar in non-epileptic (13.5 ± 0.6, n = 20) and epileptic rats 
(13.2 ± 0.7, n=11): after this time stage 5 seizures similarly recurred in both groups for the 6 
h observation period. The two investigators confirmed concordance of these measures in 
each animal at completion of the observation period. 
 
 
Fig. 1. The schematic diagram illustrates the experimental design, the number of rats 
injected with pilocarpine (Pilo with SE) and undergoing the subsequent analyses, and the 
animals excluded by the study in each experiment. Protocol 1 refers to rats exposed to SE 
and used as a reference group to determine by EEG analysis that SE severity and duration 
were similar in all animals. Protocol 2 refers to rats tested in the MWM at day 15 post-SE 
then subjected to 1H-MRS analysis (day 22) and electrode implanted at day 50 for EEG 
analysis to detect epilepsy onset. After electrode implantation these rats did not undergo 
additional behavioral or 1H-MRS analyses until seizure detection was done at 7 months (as 
in Protocol 3). Protocol 3 refers to rats followed for 7months and longitudinally tested for 
cognitive behavior in theMWMat day 15 and day 65 post-SE, each time followed after seven 
days by 1H-MRS analysis ofmIns. After imaging sessionswere terminated, rats were 
electrode implanted at day 80 post-SE for seizure detection at 7months. All rats were tested 
for afterdischarge threshold (ADT) at the end of EEG recordings. Brain histology was done 
after animals were sacrificed at the end of the experiment. 
 
We used an additional cohort of rats (n=8) implanted with hippocampal electrodes at PN19 and 
injected with lithium and pilocarpine at PN20 and PN21, respectively, to determine by EEG 
analysis if SE was of similar severity and duration in all animals (Protocol 1, Fig. 1). SE onset 
was defined by the appearance of continuous spikes with amplitude N2- fold baseline and 
frequency N 5Hz while the end of SE was set as the time the inter-spike interval becomes 
consistently N2 s (Pitkanen et al., 2005). Spikes were defined as sharp waves with an amplitude 
at least 2-fold higher than the baseline and a duration of N20 ms, or as a spike-and-wave with 
a duration of b200 ms (Pitkanen et al., 2005). Electrode-implanted rats were continuously 
(24/7) EEG recorded from 30 min before pilocarpine administration (to assess EEG baseline 
activity) until 48 h after injection. The EEG analysis showed that the onset of 
SE (16.0 ± 1.1 min), its duration (22.6 ± 0.5 h), the temporal distribution of spikes (Clampfit 
v10.0; Axon Instruments, Union City, CA, U.S.A), and the power spectral densities distribution 
of 5 frequency bands (delta: 1–4 Hz; theta: 4–8 Hz; alpha: 8–13 Hz; beta: 13–30 Hz; gamma: 
30–40 Hz; Lab Chart, AD Instrument Ltd., Oxford, UK) during the first 3 h of SE were similar 
in all animals (not shown). After SE monitoring, these rats were not further investigated since 
they were only used as a “reference” group for rats where SE was behaviorally scored (see 
above). 
 
2.3. Detection of recurrent spontaneous seizures and after discharge threshold Rats 
undergoing EEG recordings (Fig. 1) were electrode implanted under general gas anesthesia 
(1.4% isoflurane in a mixture of 70% N2O-30%O2). A bipolar nickel-chrome wire-insulated 
electrode (60 μm) was implanted unilaterally randomly in the septal left or right pole of the 
hippocampus at the following coordinates from bregma: mm: anteroposterior [AP] −3.3; nose 
bar −2.5 mm, L ± 2.4 and 3 mm below dura mater (Paxinos and Watson, 2005). Moreover, a 
cortical electrode was implanted onto the somatosensory cortex in the contralateral 
hemisphere. The electrodes were connected to a multipin socket and secured to the skull by 
acrylic dental cement.    
 
In this SE model, spontaneous seizures typically develop after a latent phase of around 70 
days (Dubé et al., 2001; Leroy et al., 2011). To double check the duration of the latent phase 
in our experimental conditions, the 14 rats of Protocol 2 were video-EEG recorded (24/7) from 
day 60 to day 75 post-SE (Fig. 1). According to the literature evidence, spontaneous seizures 
were detected at day 68.8 ± 1.8 (2.8 ± 0.6 seizures in 2 weeks) in 5 rats, denoting that this was 
the time approaching epilepsy onset. After day 75, 3 rats still without seizures lost their EEG 
implant and one rat died during severe seizures, therefore these animals were excluded from 
this study. The 10 remaining rats were again video- EEG recorded at 7 months post-SE: 7 rats 
developed spontaneous seizures (epileptic; which includes the 5 rats already developing 
epilepsy around day 70) while 3 rats did not develop seizures (non-epileptic). Since data 
showed that the latent phase in this model lasts for at least 70 days, we carried out our 
longitudinal behavioral and MRI analyses within this time frame. 
 
Rats in Protocol 3 (n = 21; Fig. 1) were video-EEG monitored at 7 months post-SE for two 
weeks (24/7) to determine and quantify spontaneous seizures. We found that 13 out of 21 
rats developed spontaneous motor seizures (epileptic) while the remaining 8 rats showed no 
seizures (non-epileptic). Therefore the average incidence of epilepsy in this model (5.8 ± 1.5 
seizures in 2 weeks in Protocols 2 and 3) was between62% and 70%, in agreement with 
previous studies where animals were recorded at least 3 months post-SE (Kubova et al., 2004; 
Marcon et al., 2009). 
 
We also measured the rat hippocampal after discharge threshold (ADT) at the end of EEG 
monitoring as a measure of local excitability. Animals were electrically stimulated via the 
hippocampal electrode, using constant current stimulus (1 ms monopolar square waves, 
50 Hz for 2 s). Determination of the ADT was done using an ascending stepwise procedure 
(Frigerio et al., 2012). The initial stimulus intensity was 50 μA and was increased by 10 μA up 
to 100μA, and then by 100 μA up to a maximal value of 400 μA by intervals of 1min, until one 
AD of at least 10 s duration was elicited. ADT was reduced by 50% in epileptic rats (103 ± 18 
μA; n = 20) compared to control rats not exposed to SE (220± 40 μA, n=9). Non-epileptic rats 
showed an ADT similar to control rats (223 ± 22 μA, n=11). AD duration did not differ among 
the 3 experimental groups (sec; control: 19.1±2.6; non-epileptic: 23.3±4.0; epileptic: 
26.0±6.1). Twenty-four hours later, rats were killed for brain histological analysis. 
 
2.4. Morris water maze (MWM) The MWM apparatus consisted of a circular pool (diameter 
150 cm, height 60 cm) filled with water, opaque by the addition of a brown food dye (depth 
30 cm, temperature 25±1 °C). The circular pool was ideally divided in four quadrants, and a 
squared platform (11 × 11 cm) was placed 1 cm below the water surface in the center of one 
quadrants. The test was performed twice in the same rat, at day 15 and day 65 post-SE, unless 
otherwise indicated (Fig. 1). The position of the platform was kept in the same quadrant 
during the first behavioral test, then was moved to a different quadrant during the second 
exposure to the same behavioral test. Each rat underwent one training session per day, which 
included four swims; daily training sessions were done for five consecutive days. During each 
training session, rats were placed into the pool starting from each of the four quadrants 
(north, west, south and east) with the head facing towards the wall of the pool. The escape 
latency, i.e. the time to reach the hidden platform, was measured. Each rat was allowed to 
swim until the platform was found or rat had swum unsuccessfully for 60 s. In the latter case, 
the rat was guided to the platform by the investigator and its escape latency was recorded as 
60 s. After 10 s rest on the platform, the rat was transferred into its home cage. 
 
Rat movements were monitored by a video camera connected to a digital tracking device 
(Noldus, Ethovision, The Netherlands). 2.5. 1H-MRS analysis and spectra quantification 
Animals were imaged at day 22 and day 72 post-SE, i.e., seven days after the MWM test (Fig. 
1), under general gas anesthesia (1.4% isoflurane in a mixture of 70% N2O-30%O2). 
Respiratory rate and temperature were continuously monitored. Experiments were done on 
a 7T Bruker Biospin 70/30 Avance III system, equipped with a 12 cm diameter gradient coil 
(400 mT/m maximum amplitude). A transmit cylindrical radio frequency (rf) coil (7.2 cm inner 
diameter) and a receive surface rf (2 × 2 cm) coil array positioned over the animal head were 
used. Localized proton spectroscopy was performed as previously described (Filibian et al., 
2012). Briefly, a PRESS (Point Resolved Spectroscopy) sequence (repetition time TR/TE = 
2500/10 ms, 512 scans, spectral width 20 ppm, 8192 points) was carried out in a single voxel 
(14 μL) positioned randomly in the septal left or right pole of the hippocampus. Water 
suppression was performed with VAPOR and first and second order shims were adjusted using 
FASTMAP (Fast, Automatic Shimming technique by Mapping Along Projections). 1H-MRS 
spectra were quantified using TARQUIN 4.2.1 (Wilson et al., 2011) for the estimation of mIns 
levels. Each spectrum was pre-processed by applying automated zero-order phasing and 
referencing, and by performing residual water line removal with the HSVD method. The 
processed signal was fit to a linear combination of selected metabolites. The reliability and 
quality of the fitting procedure was assessed both by visual inspection and by checking the 
quality parameter Q retrieved by TARQUIN The mean value of Q was included between 1.15 
and 1.3, indicating a very high fit quality (Q= 1 corresponds to a perfect fit) (Wilson et al., 
2011). The amplitudes of the mIns signals obtained by the fit that had a CRLB (Cramer-Rao 
lower bound) higher than 35% were excluded from the results. Relative mIns levels were then 
derived by scaling the fitted amplitudes by the amplitude of the total Creatine (tCr: Cr + 
phospho Cr) signal, considered as the internal standard. 
 
 
 
Fig. 2. Cognitive performance in Morris Water Maze during epileptogenesis. Panel A depicts 
the escape latency during the 5 days of training in controls (n=33), non-epileptic (n=11) and 
epileptic rats (n=20) at day 15 post-SE. *p b 0.05 vs control; #pb 0.05 vs non-epileptic, by one-
way ANOVA followed by Dunn's test. Panel B shows the rate of learning at 15 days after SE: 
the difference between the escape latency in trials 1 and 5, normalized to the escape latency 
in trial 1. Epileptic rats showed a slower rate of learning compared to non-epileptic rats and 
controls *p b 0.05 vs control; #pb 0.05 vs non-epileptic by one-way ANOVA followed by Dunn's 
test. Panel C depicts the ROC curve obtained by comparing the rate of learning of epileptic vs 
non-epileptic rats; the AUC = 0.79 indicates that this parameter discriminates with good 
accuracy the two cohorts of animals. Panel D depicts the escape latency during the 5 days of 
training in controls (n = 32), non-epileptic (n = 8) and epileptic rats (n = 13) at day 65 post-SE. 
**p b 0.01 vs control; #p b 0.05 vs non-epileptic, by one-way ANOVA followed by Dunn's test. 
Panel E shows daily comparison during the 5 days of training of the escape latency measured 
during the last training session of each day (Trial 4) with the escape latency measured during 
the first session of the subsequent day (Trial 1) at 65 days post-SE in epileptic and non-
epileptic rats. Epileptic rats had poorer overnight retention (i.e. accelerated forgetting) 
compared to non-epileptic rats. *p b 0.05 vs trial 4 at days 3 and 4. Panel F depicts the ROC 
curve obtained by comparing the accelerated forgetting of epileptic vs nonepileptic rats; the 
AUC = 0.84 indicates that this parameter discriminates with excellent accuracy the two 
cohorts of rats. 
 
2.6. Tissue preparation for immunohisto chemical analysis 
Twenty-four hours after measuring the ADT, rats were deeply anaesthetized using ketamine 
(150 mg/kg) and medetomidine (2.0 mg/kg) and perfused via ascending aorta as previously 
described (Marcon et al., 2009). The brains were post-fixed for 90 min at 4 °C, transferred 
to 20% sucrose in PBS for 24 h at 4 °C, frozen in n-pentane for 3 min at −50 °C, and then stored 
at−80 °C until assayed. Immunohistochemistry (IHC) was done to detect glia activation (S100β 
for astrocytes; OX- 42 for microglia) and neurogenesis (double cortin, DCX). Nissl staining was 
performed to assess neuronal cell loss. All the analyses were done in 6 vehicle-injected rats 
(controls) and 14 pilocarpine-treated rats (n=7 epileptic;n=7non-epileptic) randomly taken 
among the rats included in Protocols 2 and 3 (Fig. 1), except for stereological counting and 
neurogenesis that was done in 5 randomly chosen rats in each group. Serial coronal sections 
(40 μm) were cut on a cryostat throughout the septo-temporal extension of the hippocampus 
(−2.3 to −5.8 mm from bregma) according to Paxinos & Watson atlas (Paxinos and Watson, 
2005). We prepared 8 series of 10 sections each (4 series including the septal and 4 series 
including the temporal aspect of the hippocampus). In each series, the 1st and 5th sections 
were stained for Nissl. In the 1st, 3th, 6th and 8th series, the 2th section was stained for 
S100β, the 3rd for OX-42 and the 4th for DCX. S100β, OX-42 and DCX immunostaining was 
carried out as previously described (Filibian et al., 2012; Iori et al., 2013). We previously 
established lack of signal when slices were incubated with the primary antibodies pre 
absorbed with the corresponding peptides, or without the primary antibodies. 
Immunohistochemical analysis of brain sections (plates 19–22) (Paxinos and Watson, 2005) 
and quantification procedures were performed by two independent expert investigators blind 
to the identity of the samples. 
 
Neuronal cell loss was quantified by reckoning the number of Nisslstained neurons in CA1 and 
CA3 pyramidal cell layers and the hilar interneurons using an image of the whole hippocampus 
captured at 20× magnification (Virtual Slider Microscope; Olympus, Germany) and digitized 
(n = 6 control; n = 7 epileptic; n = 7 non-epileptic; 4 slices/rat). In addition, stereological 
analysis in Nissl-stained sections was performed (n=5 each group; 3 slices/rat). The nucleoli 
of pyramidal neurons (CA1 and CA3) and hilar interneurons were counted at 40× 
magnification using an Eclipse E600 microscope equipped with Optronics Micro Fire digital 
camera (Nikon, Japan). The neuronal density was estimated with the Optical Fractionator 
technique, using a computer-assisted microscope and the Stereo Investigator software (Micro 
Bright Field), as previously described (Spigolon et al., 2010). A 4 μm guard zone, a 50 μm × 50 
μm counting frame size and a 100 μm × 100 μm grid layout were employed. Data obtained in 
both hippocampi in each rat were averaged, thus providing a single value for each rat, and 
this value was used for the statistical analysis. 
 
The total number of S100β-immunore active astrocytes was counted in the whole 
hippocampus (20× magnification) by an investigator who visually identified the cells; then an 
automated cell count was generated using ImageJ software (n=6 
control;n=7epileptic;n=7nonepileptic; 2 slices/rat). 
 
 
 
 
 
Fig. 3. 1H-MRS analysis of mIns/tCr levels in the hippocampus during epileptogenesis. 
Representative 1H-MRS spectra acquired at day 22 (A-C) or day 72 (D-F) post-SE in control 
(A,D), nonepileptic (B,E) and epileptic rats (C,F). Spectra and fit residuals (upper row) are 
plotted in blue, metabolite fits are plotted in green, and mIns contribution is plotted in red. 
Panel G depicts the mIns/tCr levels (mean ± s.e.m.) in the various experimental groups at 
day 22 (controln = 9; non-epileptic n=11; epileptic n=20) and day 72 (control n = 9; non 
epilepticn = 8; epileptic n=13) post-SE. At day 22,mIns/tCr levelswere increased similarly in 
epileptic and non-epileptic rats compared to controls while at day 72 themIns/tCr increase 
persisted only in epileptic rats. *p b 0.05 vs control; #pb 0.05 vs non-epileptic by one-way 
ANOVA followed by Dunn's test. Panel H depicts the ROC curve obtained by comparing 
mIns/tCr levels in epileptic vs non-epileptic rats at day 72 post-SE; the AUC = 0.83 indicates 
that this parameter discriminate with excellent accuracy the two cohort of rats. 
 
OX-42-immunostained area was measured in the whole hippocampus (20× magnification) 
using ImageJ software, and data were expressed as positive pixels/total assessed pixels; the 
percent area with the specific staining was used for subsequent statistical analysis (n= 6 
control; n=7epileptic; n = 7 non-epileptic; 2 slices/rat). The analysis of DCX-immunostained 
sections (n=5 rats each group; 4 slices/rat)was performed using a Zeiss slide scanner 
(Axioscanner Z1, Zeiss, Germany) and a Zeiss ZEN2 software (v1.0 EN 1.0) at 5×, 10× and 20× 
magnifications, and each hippocampus was reconstructed into a tiled image using Zeiss 
software. DCX-positive cells in the subgranular zone were counted in each dentate, as 
previously described (Zaben et al., 2009). For Sholl analysis, one DCX-stained cell/dentate 
blade/dentate/ section was randomly chosen and the dendritic tree was analysed using 
ImageJ software (FIJI, v2.0.0-rc-43/150e) with the Simple Neurite Tracer Plug-in. Sholl analysis 
was confined to DCX-positive cells with a dendritic tree extending into the molecular layer. 
Dendritic processes were semi-automatically traced in ImageJ (v1.49, NIH), and the number 
of dendritic intersections across concentric Sholl circle radii rings at intervals of 10 μm was 
recorded. 
 
2.7. Randomization, blinding procedures and statistical analysis of data Sample size was a 
priori determined based on previous experience with the animalmodel and the respective 
behavioral and imaging analyses. Simple randomization was applied to assign a subject to a 
specific experimental group (vehicle or pilocarpine treatment) using a web site randomization 
program (http://www.randomization.com). One day after vehicle or pilocarpine injection, 
rats were linked to numerical identifiers by an external investigator not involved in the study 
and unaware of the treatment. This procedure ensured that animal handling and data 
acquisition during the longitudinal analyses were done by investigators blinded to the identity 
of the animals. After epileptic and non-epileptic rats were identified based on the presence 
of spontaneous seizures at 7 months, the external investigator generated two considered 
excellent for AUC values close to 1. Differenceswere considered significant with a p b 0.05. 
 
3. Results 
After grouping the animals at 7months post-SE in epileptic and nonepileptic rats, based on 
the presence of spontaneous seizures and the ADT, we retrospectively analysed and 
compared their behavioral performance in the MWM (Fig. 2) and their respective mIns levels 
by 1HMRS (Fig. 3) that were both assessed before the predicted time of epilepsy onset. 
 
3.1. Evaluation of animal performance in Morris Water Maze During the 5 days of training, 
the overall statistical analysis indicates that the three experimental groups (control, non-
epileptic and epileptic rats) performed differently both at day 15 (Fig. 2A) and at day 65 
(Fig. 2D) post-SE [Group x Trial interaction: day 15: F(8,236) = 1.95, p b 0.05; day 65: F(8,200) 
= 1.98, p b 0.05]. At day 15, all rats learned to find the hidden platform independently of the 
experimental group, as indicated by the progressive reduction in the escape latency over the 
5 training days (Fig. 2A). However, epileptic and non-epileptic rats had a 2-fold longer escape 
latency on average than controls in trials 3 and 4 (Fig. 2A; p b 0.05). In trial 5, this deficit was 
maintained only in epileptic rats (Fig. 2A; p b 0.05). In accordance, the escape latency did not 
improve during the last 3 trials in epileptic rats (p b 0.05 vs both control and non-epileptic 
rats). Epileptic rats also showed a slower rate of learning (p b 0.05) compared to non-epileptic 
rats and controls (Fig. 2B). The ROC curve obtained by comparing the rate of learning of 
epileptic vs none pileptic rats showed an AUC=0.79 (p=0.01; Fig. 2C). At day 65 post- SE, the 
learning performance of the three experimental groups was similar to day 15 (Fig. 2D vs A). 
Notably, a new behavioral feature was specifically observed in epileptic rats: comparison of 
the escape latency of the last training session of each day with the escape latency of the first 
training session of the subsequent day showed that epileptic rats had a poor overnight 
memory retention (i.e., accelerated forgetting) compared to non-epileptic rats, a 
phenomenon developing over the 5 day trials (Fig. 2E). The correspondent ROC curve had an 
AUC value of 0.84 (p=0.009; Fig. 2F). In SE-exposed rats, we did not observe any clinical seizure 
during the training period. 
 
 
 
 
 
3.2. 1H-MRS analysis of mIns  
 
One week after the end of each behavioral test, all rats underwent 1H-MRS analysis in the 
dorsal hippocampus for measuring mIns levels (Fig. 3). At day 22, mIns/tCr levels increased 
by 20% on average in both epileptic and non-epileptic rats compared to controls (0.59 ± 0.02 
arbitrary unit; Fig. 3A–C, G). At day 72, this increase persisted only in epileptic rats (Fig. 
3F,G)whilemIns/tCr levels declined in non-epileptic rats to control levels (Fig. 3E,G). The 
ROC curve comparing epileptic vs nonepileptic rats at day 72 showed an AUC = 0.83 (p= 
0.01). 
 
The accuracy of discrimination between SE-rats thatwill develop epilepsy from those rats not 
developing the disease was increased by reckoning the ratio between rate of learning at day 15 
and mIns/tCr levels at day 72 (Fig. 4A) as shown by the ROC curve with an AUC = 0.9 (p = 
0.0027; Fig. 4B).  
 
3.3. Brain histology  
At completion of EEG recording and ADT measurements, we analysed cell loss, glia activation 
and neurogenesis in the septal pole of the hippocampus of randomly selected rats since this 
area is especially involved in cognitive processes (Broadbent et al., 2004). 
 
   
Fig. 5. Histological analysis of the hippocampus at 7 months post-SE in rats with and without 
spontaneous seizures. Panels A and B depict the quantification of neuronal cells in CA1 and 
CA3 pyramidal layers and in the hilus estimated by counting the Nissl-stained neurons (A) and 
by stereological analysis (B) in control (n=5–6), non-epileptic (n=5–7) and epileptic (n=5–7) 
rats. In control hippocampi, the number of neuron/section was (mean±s.e.m., n=6) CA1: 
1279±25; CA3: 546±15; hilus: 93.9±7 (A); cells/mm3 x 103 (mean±s.e.m., n=5) CA1: 
159.1 ± 12.1; CA3: 95.3 ± 5.8; hilus: 11.2 ± 1.8 (B). *p b 0.05, **p b 0.01 vs control by one-way 
ANOVA followed by Dunn's test. Panel C shows the number of S100β-immunoreactive 
astrocytes in control (n = 6), non-epileptic (n = 7) and epileptic (n = 7) rats. The number of 
cells (mean ± s.e.m., n = 6) in control was 1.891 ± 139. Microphotographs in panel C depict 
representative images of S100β-positive astrocytes in CA1 pyramidal cell layer in the various 
groups. *p b 0.05 vs control, ##p b 0.01 vs non-epileptic by one-way ANOVA followed by 
Dunn's test. Scale bar: 100 μm. Panel D depicts the quantification of DCX-positive neurons in 
the dentate gyrus in the various experimental groups (n= 5 rat each group). The number of 
DCX cells in control was 66.8 ± 8 (mean ± s.e.m.). **p b 0.01 vs control, ##p b 0.01 vs non-
epileptic by one-way ANOVA followed by Dunn's test. Panel E shows Sholl analysis in epileptic 
and non-epileptic rats showing similar compromission in dendrite complexity. 
 
3.3.1. Neuronal cell loss 
A reduction of the total number of hilar interneurons (by 60% on average; p b 0.01 vs control) 
and CA3 pyramidal cells (by 18% on average; p b 0.05 vs control, n = 6) was found in all SE-
rats independently on whether or not they developed spontaneous seizures (Fig. 5A; n=7 
epileptic, n = 7 non-epileptic). Stereological analysis confirmed that cell loss was similar in all 
rats showing around 55% reduction of hilar interneurons (p b 0.05) and 40% reduction of CA3 
pyramidal cells (p b 0.01) vs controls (Fig. 5B) (n=5 each group). The number of CA1 pyramidal 
neurons was not significantly reduced in SE-rats compared to controls (Fig. 5A, B). 
 
3.3.2. Glia activation 
OX-42-positive microglia showed small cell bodies and extensive ramifications denoting their 
resting state in all three experimental groups (not shown). Accordingly, the percent 
hippocampal area occupied by the specific OX-42 signal in epileptic (10.6 ± 0.6%, n = 7) and 
non-epileptic (8.5 ± 1.1%, n = 7) rats was similar to control rats (9.4 ± 0.8%, n = 6). 
 
Differently, we found that the number of S100β-positive astrocytes was increased by 
27.1±5.2% in epileptic rats (n=7, p b 0.05) compared to controls (n=6) while no difference was 
found between non-epileptic (n= 7) and control rats (Fig. 5C). 
 
3.3.3. Neurogenesis 
There was an overall significant difference in the number of newly born DCX-positive neurons 
in the dentate gyrus among the three experimental groups (p b 0.01). A significant 50% 
reduction in these cells was found in epileptic vs control rats while non-epileptic rats were 
similar to controls (Fig. 5D; n=5 each group). The dendritic arborization of DCX positive cells 
with dendrites extending through the granule cell and molecular layers was examined in 18 
cells from epileptic rats, 22 cells from non-epileptic rats and 16 cells from control rats using 
Sholl analysis. The analysis of the AUC of the mean crossings per cell showed a significant 
effect of the group (p b 0.01) revealing differences between epileptic and control rats (p b 
0.01) and non-epileptic and control rats (p b 0.05) (Fig. 5E). Epileptic and non-epileptic rats 
had less complex dendritic trees, especially distally, with this phenomenon more marked, 
although not significantly, in epileptic rats (Fig. 5E). 
 
4. Discussion 
We report the novel evidence that cognitive deficits in a spatial memory test together with 
astrocyte activation in the hippocampus, predict the development of epilepsy in a rat model 
of de novo SE with high accuracy. This model is highly valuable for determining factors 
associated with epilep to genesis since only a cohort of rats develop spontaneous seizures 
after an inciting event of similar severity and duration (Marcon et al., 2009; Roch et al., 2002). 
In accord, we found that only 70% of rats developed epilepsy, although SE was similar in all 
rat. In support, hippocampal cell loss, an objective measure of SE severity (Fujikawa, 1996), 
did not differ among animals. 
 
We identified epileptic and non-epileptic rats based on the detection of video-EEG seizures at 
7 months post-SE. We monitored rats for two weeks, which allows seizure detection based 
on their mean frequency, i.e., one seizure every three days. Although we cannot exclude that 
seizures might have occurred at later time points in non-epileptic rats, this is unlikely based 
on literature evidence related to this model (Kubova et al., 2004). Additionally, ADT in non-
epileptic and control rats was similar while it was significantly reduced in epileptic rats, thus 
supporting the lack of chronic excitability changes in rats without seizures. 
 
Our retrospective data analysis showed that SE-exposed rats developed early cognitive 
deficits in a spatial learning task. Impaired cognitive functions were previously reported to 
occur before epilepsy onset during both post-natal development (Cilio et al., 2003; Kubova et 
al., 2004; Liu et al., 1994; Sayin et al., 2004) and in adulthood (Chauviere et al., 2009; Hort et 
al., 2000; Jones et al., 2010) but it was unknown whether these deficits correlated with 
epilepsy development. We describe for the first time that a reduced rate of learning and an 
accelerated forgetting are two specific features of rats prone to develop epilepsy, and these 
deficits anticipate the onset of spontaneous seizures. 
 
Notably, impaired spatial learning and accelerated forgetting were also described in temporal 
lobe epilepsy (TLE) patients exposed to a virtual MWM task (Barkas et al., 2012) and cognitive 
deficits were documented in children and adult before the first recognized seizures or at the 
early stages of the disease (Hermann et al., 2006; Oostrom et al., 2003; Witt and 
Helmstaedter, 2015). This clinical evidence highlights the high translational significance of our 
findings. 
 
Our results, together with evidence that cognitive deficits and the propensity to develop 
epilepsy after SE both increase with age (Cilio et al., 2003; Kubova et al., 2004; Sayin et al., 
2004), reinforce the hypothesis that they share common molecular changes (Devinsky et al., 
2013; Todd et al., 2006). In this respect, we found that persistent astrocyte activation in the 
hippocampus is a specific feature of epilepsy-prone rats, as shown by longitudinal 1H-MRS 
analysis of mIns/tCr levels and by post-mortem analysis of S100β-positive astrocytes. Similar 
changes in these measures were reported in adult rat models where all animals develop 
epilepsy (Filibian et al., 2012; Wu et al., 2015; Zahr et al., 2009). Altogether, these data suggest 
that S100β-expressing astrocytes contribute to the mIns changes during epilepto genesis and 
may play a role in both cognitive impairment and seizure generation. Accordingly, mice 
overexpressing S100β show spatial memory impairment (Gerlai et al., 1995) while S100β 
knock-out mice exhibit enhanced spatial learning in the MWM (Nishiyama et al., 2002). 
S100β-induced modifications of intracellular Ca2+ in astrocytes (Barger and Van Eldik, 1992) 
and in neurons by activation of RAGE receptors (Huttunen et al., 2000) appear to be involved 
in the modulation of synaptic plasticity. S100β released by astrocytes may also promotes 
changes in neuronal rhythms that are relevant for seizure onset (Morquette et al., 2015; 
Sakatani et al., 2008), and RAGE receptors are implicated in both cognitive impairments 
(Mazarati et al., 2011) and epileptogenesis (Iori et al.,2013). In this context, there is increasing 
evidence that activated astrocytes play a key role in neuronal network hyperexcit ability 
underlying seizures (Devinsky et al., 2013; Robel et al., 2015). 
 
Neurogenesis is another biological process implicated in cognitive dysfunctions in TLE 
(Hattiangady et al., 2004; Scharfman and Gray, 2007) and aberrant neuronal network 
excitability (Scharfman et al., 2000). In particular, a negative correlation was reported 
between the number of DCX-positive neurons in surgically resected TLE hippocampi and the 
memory functions in the respective patients before surgery (Coras et al., 2010). Our data 
show that epileptic rats had reduced levels of dentate neurogenesis compared to controls 
and non-epileptic rats. Altered neurogenesis is present immediately after SE during 
epileptogenesis (Gray and Sundstrom, 1998; Parent et al., 1997), at the time of our behavioral 
analysis, as well as chronically in TLE (Hattiangady et al., 2004), and thus might contribute to 
the progressive cognitive impairment we observed in rats prone to develop epilepsy. Other 
cellular alterations induced by SE such as reduction in dendritic spine density (Jiang et al., 
1998) and place cells dysfunctions (Holmes, 2015) have been associated with cognitive 
impairment (Holmes, 2015; Jiang et al., 1998) and could play a role, together with the less 
complex dendritic arborization of DCX-positive neurons in SE-rats, to the behavioral deficits 
that precede epilepsy development in our model. 
 
5. Conclusions 
 
This study provides the first proof-of-principle demonstration that assessment of cognitive 
abilities and 1H-MRS analysis of mIns in seizure-prone brain areas following potential 
epileptogenic injuries may represent clinically meaningful biomarkers for early identification 
of individuals at high-risk for developing epilepsy (Betjemann and Lowenstein, 2015; Herman, 
2002; Raspall-Chaure et al., 2006). Although our findings are related to a model of SE-induced 
epilepsy, increased mIns brain levels were found to be associated with neurological 
dysfunctions in children and adults after traumatic brain injury (Ashwal et al., 2004; Brooks et 
al., 2000; Garnett et al., 2000), although no attempts were made to correlate these measures 
with epilepsy development. This evidence, therefore, potentially extends the significance of 
our findings to epileptogenic injuries other than SE, such as neurotrauma, ischemic stroke or 
CNS infections. If applied and validated in the clinical setting these non-invasive measures 
could greatly facilitate the clinical development of novel preventive antiepileptogenic 
therapies. 
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